XNAS: MURA

Download real time

4.07 0.17 (4.36%)

41.81% Gain from 52W Low

90,757 XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

70.1

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Mural Oncology plc is on 26 Mar 2025 for the purpose of Mural Oncology PLC Fourth Quarter Earnings Results for 2024 See details

Insider Trading disclosures for Mural Oncology plc

The latest disclosure was made by Caroline Loew in Mural Oncology plc where a trade of 134,225 Stock Option (right to buy) done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Caroline Loew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	134,225	134,225	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	35,000	76,295	-		0	Ordinary Shares
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	65,000	65,000	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Sale of securities on an exchange or to another person at price $ 3.45 per share.	03 Mar 2025	1,469	73,564	-	3.4	5,068	Ordinary Shares
Maiken Keson-Brookes	See Remarks	Sale of securities on an exchange or to another person at price $ 3.36 per share.	03 Mar 2025	1,262	75,033	-	3.4	4,240	Ordinary Shares
Adam D. Cutler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	35,000	106,438	-		0	Ordinary Shares
Adam D. Cutler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	65,000	65,000	-		-	Stock Option (right to buy)
Vicki L. Goodman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	65,000	65,000	-		-	Stock Option (right to buy)
Vicki L. Goodman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	35,000	89,763	-		0	Ordinary Shares
Caroline Loew	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.36 per share.	03 Mar 2025	4,313	305,590	-	3.4	14,492	Ordinary Shares
Caroline Loew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	72,275	309,903	-		0	Ordinary Shares
Vicki L. Goodman	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.89 per share.	24 Feb 2025	13,186	54,763	-	3.9	51,294	Ordinary Shares
Keson-Brookes Maiken	See Remarks	Sale of securities on an exchange or to another person at price $ 3.27 per share.	23 Dec 2024	2,555	41,295	-	3.3	8,355	Ordinary Shares
Loew Caroline	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.40 per share.	17 Dec 2024	2,763	237,628	-	3.4	9,394	Ordinary Shares
Vicki L. Goodman	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.33 per share.	07 Nov 2024	5,069	67,949	-	3.3	16,880	Ordinary Shares
Adam D. Cutler	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.41 per share.	31 Oct 2024	7,421	71,438	-	3.4	25,306	Ordinary Shares
Sachiyo Minegishi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	15,335	15,335	-		-	Stock Option (right to buy)
Susan Altschuller	Director	Purchase of securities on an exchange or from another person at price $ 3.21 per share.	14 Aug 2024	10,000	10,000	-	3.2	32,071	Ordinary Shares
George S. Golumbeski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jul 2024	15,334	15,334	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Sale of securities on an exchange or to another person at price $ 3.41 per share.	18 Jul 2024	2,157	43,850	-	3.4	7,355	Ordinary Shares
Caroline Loew	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 2.91 per share.	08 Jul 2024	12,531	240,391	-	2.9	36,465	Ordinary Shares
Susan Altschuller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Benjamin J. Hickey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Francis M. Cuss	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Scott T. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Susan Altschuller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Benjamin J. Hickey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Francis M. Cuss	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Scott T. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	8,462	8,462	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	31,200	31,200	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	16,800	46,007	-		0	Ordinary Shares
Caroline Loew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	48,475	252,922	-		0	Ordinary Shares
Caroline Loew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	90,025	90,025	-		-	Stock Option (right to buy)
Susan Altschuller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	15,021	15,021	-		-	Stock Option (right to buy)
Benjamin J. Hickey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	15,021	15,021	-		-	Stock Option (right to buy)
Adam D. Cutler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	78,859	78,859	-		0	Ordinary Shares
Adam D. Cutler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	146,452	146,452	-		-	Stock Option (right to buy)
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	29,207	29,207	-		0	Ordinary Shares
Maiken Keson-Brookes	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	54,242	54,242	-		-	Stock Option (right to buy)
Francis M. Cuss	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	15,021	15,021	-		-	Stock Option (right to buy)
Scott T. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	15,021	15,021	-		-	Stock Option (right to buy)
Vicki L. Goodman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	73,018	73,018	-		0	Ordinary Shares
Vicki L. Goodman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	135,604	135,604	-		-	Stock Option (right to buy)
Caroline Loew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2023	379,690	379,690	-		-	Stock Option (right to buy)

Showing 1 to 44 of 44 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

41.81% Gain from 52W Low

Insider Trading disclosures for Mural Oncology plc

The latest disclosure was made by Caroline Loew in Mural Oncology plc where a trade of 134,225 Stock Option (right to buy) done was reported to US exchanges on March 3, 2025.

Screeners based on Insider Trading and SAST parameters